Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| GALECTIN THERAPEUTICS INC | 91,000 | reported | 16 Jan 2026 | tx 149+2,778,899−697,023 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 16 Jan 2026 | GRANT_AWARD | GALECTIN THERAPEUTICS INC | 84,000 | 0.00 USD | deriv |
| 16 Jan 2026 | GRANT_AWARD | GALECTIN THERAPEUTICS INC | 120,000 | 0.00 USD | deriv |
| 05 Jan 2026 | OTHER | GALECTIN THERAPEUTICS INC | 56,332 | 3.88 USD | |
| 02 Jan 2026 | EXERCISE | GALECTIN THERAPEUTICS INC | 84,000 | 0.00 USD | |
| 06 Jan 2026 | SALE | GALECTIN THERAPEUTICS INC | 37,698 | 3.58 USD | |
| 02 Jan 2026 | SALE | GALECTIN THERAPEUTICS INC | 18,571 | 4.20 USD | |
| 05 Jan 2026 | SALE | GALECTIN THERAPEUTICS INC | 27,731 | 3.91 USD | |
| 02 Jan 2026 | EXERCISE | GALECTIN THERAPEUTICS INC | 84,000 | 0.00 USD | deriv |
| 17 Dec 2025 | SALE | GALECTIN THERAPEUTICS INC | 7,829 | 7.06 USD | |
| 17 Dec 2025 | EXERCISE | GALECTIN THERAPEUTICS INC | 7,829 | 2.86 USD | |
| 17 Dec 2025 | EXERCISE | GALECTIN THERAPEUTICS INC | 7,829 | 0.00 USD | deriv |
| 17 Nov 2025 | EXERCISE | GALECTIN THERAPEUTICS INC | 15,680 | 2.39 USD | |
| 17 Nov 2025 | SALE | GALECTIN THERAPEUTICS INC | 15,680 | 6.04 USD | |
| 18 Nov 2025 | EXERCISE | GALECTIN THERAPEUTICS INC | 6,783 | 2.39 USD | |
| 18 Nov 2025 | SALE | GALECTIN THERAPEUTICS INC | 6,783 | 6.15 USD | |
| 18 Nov 2025 | EXERCISE | GALECTIN THERAPEUTICS INC | 6,783 | 0.00 USD | deriv |
| 17 Nov 2025 | EXERCISE | GALECTIN THERAPEUTICS INC | 15,680 | 0.00 USD | deriv |
| 10 Nov 2025 | EXERCISE | GALECTIN THERAPEUTICS INC | 1,867 | 2.39 USD | |
| 10 Nov 2025 | SALE | GALECTIN THERAPEUTICS INC | 1,867 | 6.03 USD | |
| 05 Nov 2025 | EXERCISE | GALECTIN THERAPEUTICS INC | 1,867 | 0.00 USD | deriv |
| 05 Nov 2025 | SALE | GALECTIN THERAPEUTICS INC | 200 | 6.00 USD | anomaly |
| 05 Nov 2025 | EXERCISE | GALECTIN THERAPEUTICS INC | 200 | 2.39 USD | |
| 05 Nov 2025 | EXERCISE | GALECTIN THERAPEUTICS INC | 200 | 0.00 USD | deriv |
| 03 Nov 2025 | EXERCISE | GALECTIN THERAPEUTICS INC | 1,300 | 2.39 USD | |
| 03 Nov 2025 | SALE | GALECTIN THERAPEUTICS INC | 1,300 | 6.01 USD | anomaly |
2 purchases reported after at least 12 months of silence — most recent on 24 Apr 2024.